Back to Search
Start Over
Immunomedics drops Seattle Genetics deal.
- Source :
-
C&EN Global Enterprise . 5/15/2017, Vol. 95 Issue 20, p18-19. 2p. - Publication Year :
- 2017
-
Abstract
- The article reports on the cancellation of licensing deal by Immunomedics with Seattle Genetics for its cancer antibody IMMU-132.
- Subjects :
- *LICENSE agreements
Subjects
Details
- Language :
- English
- ISSN :
- 24747408
- Volume :
- 95
- Issue :
- 20
- Database :
- Academic Search Index
- Journal :
- C&EN Global Enterprise
- Publication Type :
- Periodical
- Accession number :
- 123222433
- Full Text :
- https://doi.org/10.1021/cen-09520-buscon007